Skip to content

A Prospective Randomized Controlled Trial comparing Direct Anterior and Posterolateral Approaches for Hip Replacement in Patients with Femoral Neck Fractures

A Prospective Randomized Controlled Trial comparing Direct Anterior and Posterolateral Approaches for Hip Arthroplasty in Femoral Neck Fractures - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/108348
Enrollment
70
Registered
2026-04-13
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: S720- Fracture of head and neck of femur

Interventions

Intervention1: Patients will undergo hip arthroplasty by direct anterior approach for femoral neck fractures: The direct anterior approach (DAA) is a muscle-sparing, inter-muscular approach and inter-

Sponsors

All India Institute Of Medical Sciences New Delhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Age can be greater than or equal to 60 years 2 Femoral neck fracture which can be displaced, non-union, or neglected 3 Planned hip arthroplasty Total Hip Arthroplasty or hemiarthroplasty 4 Ambulatory prior to fracture (with or without walking aid) 5 Informed consent obtained from patient or legally authorized representative

Exclusion criteria

Exclusion criteria: 1 Pathological fractures (tumour or infection) 2 Polytrauma (Injury Severity Score greater than 16) 3 Prior ipsilateral hip surgery 4 Non-ambulatory status prior to injury 5 Neuromuscular disorders significantly affecting gait

Design outcomes

Primary

MeasureTime frame
To compare Timed Up and Go (TUG) test scores at 2 weeks postoperatively between Direct Anterior Approach and Posterolateral ApproachTimepoint: post operatively at 2 weeks

Secondary

MeasureTime frame
To compare early mobility using the Cumulated Ambulation Score (CAS).Timepoint: post operatively at day 1, 2 and 3;To assess pain using Visual Analog Scale (VAS) , overall narcotic exposure in morphine milligram equivalents(MME) and medications for pain control will be charted during hospital stayTimepoint: post operative day 1 and 3 for VAS and assess analgesic intake at discharge;To evaluate perioperative muscle damage using serum creatine kinase (CK) , serum C-reactive protein (CRP), serum lactate dehydrogenase(LDH), serum myoglobinTimepoint: post operative day 1 and 3;To compare radiographic outcomes including Femoral stem alignment Stem subsidence Leg length discrepancy Offset restoration Timepoint: post operatively at 3 and 6 months;To assess perioperative outcomes such as operative time, blood loss, transfusion rate, and length of hospital stay.Timepoint: intraoperatively and during course of hospital stay;To compare complication rates including dislocation, periprosthetic fracture, wound complications and 30-day mortality.Timepoint: mortality rate at 30 days and complications upto a follow up period of 6 months;To evaluate short-term functional outcome using Forgotten Joint Score ,Harris Hip Score, Barthel score and Hoos JR score at 3 monthsTimepoint: at 3 months post operatively

Countries

India

Contacts

Public ContactDr Chaitanya Gupta

All India Institute of Medical Sciences New Delhi

sahilbatra25@gmail.com9899816498

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026